Ranabir Majumder

6PUBLICATIONS
14CO-AUTHORS
Microbial taxonomyCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
Taxonomic Resolution of 16S rRNA, FastANI, Mash, and FastAAI across 30,495 Prokaryotic Type-Strain Genomes.

|Oct 31, 2025
Modified PAMAM Dendrimer-Based Carboplatin Delivery in Glioblastoma: In Vitro and In Vivo Studies.

Madhurima Mandal, Dipanjan Samanta, Debolina Manna

|Feb 13, 2025
CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting.

Priya Ghosh, Ankita Dey, Suvendu Nandi

|May 04, 2023
In-silico identification of novel DDI2 inhibitor in glioblastoma via repurposing FDA approved drugs using molecular docking and MD simulation study.

Pritam Kumar Roy, Ranabir Majumder, Mahitosh Mandal

|Sep 08, 2020
Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an in silico docking and molecular dynamics simulation approach.

Ranabir Majumder, Mahitosh Mandal

|Jul 25, 2020
In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents of Calendula officinalis.

Pratik Das, Ranabir Majumder, Mahitosh Mandal

Pageof 1

Frequent Collaborators

2 joint publications

Mahitosh Mandal

1 joint publications

Pratik Das

1 joint publications

Piyali Basak

1 joint publications

Priya Ghosh